Cargando…

In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014–2015

Enmetazobactam, formerly AAI101, is a novel penicillanic acid sulfone extended-spectrum β-lactamase (ESBL) inhibitor. The combination of enmetazobactam with cefepime has entered clinical trials to assess safety and efficacy in patients with complicated urinary tract infections. Here, the in vitro ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morrissey, Ian, Magnet, Sophie, Hawser, Stephen, Shapiro, Stuart, Knechtle, Philipp
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Epidemiology and Surveillance
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591593/ https://www.ncbi.nlm.nih.gov/pubmed/30988152 http://dx.doi.org/10.1128/AAC.00514-19

Ejemplares similares

1945. Antibacterial activity of cefepime/enmetazobactam and comparator agents against U.S. Enterobacterales clinical isolates collected from 2019-2021
por: Belley, Adam, et al.
Publicado: (2023)

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017
por: Morrissey, Ian, et al.
Publicado: (2020)

Activity of Meropenem-Vaborbactam against Bacterial Isolates Causing Pneumonia in Patients in U.S. Hospitals during 2014 to 2018
por: Carvalhaes, Cecilia G., et al.
Publicado: (2020)

Activity of the Novel Extended-spectrum β-Lactamase Inhibitor AAI101 in Combination with Cefepime Towards a Challenge Panel of Acinetobacter baumannii
por: Morrissey, Ian, et al.
Publicado: (2017)

Dengue virus infections among European travellers, 2015 to 2019
por: Gossner, Céline M, et al.
Publicado: (2022)

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program
por: Pfaller, Michael A., et al.
Publicado: (2017)

Nationwide Surveillance and Molecular Characterization of Critically Drug-Resistant Gram-Negative Bacteria: Results of the Research University Network Thailand Study
por: Yungyuen, Thitiya, et al.
Publicado: (2021)

Surveillance and epidemiology of syphilis, gonorrhoea and chlamydia in the non-European Union countries of the World Health Organization European Region, 2015 to 2020
por: Barbaric, Jelena, et al.
Publicado: (2022)

Increasing Antimicrobial Resistance in Nontyphoidal Salmonella Isolates in Australia from 1979 to 2015
por: Williamson, Deborah A., et al.
Publicado: (2018)

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014
por: Mataseje, Laura F., et al.
Publicado: (2016)

Molecular Epidemiology of Emerging Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter pittii in Taiwan, 2010 to 2014
por: Chen, Feng-Jui, et al.
Publicado: (2019)

Surveillance of leishmaniasis cases from 15 European centres, 2014 to 2019: a retrospective analysis
por: Van der Auwera, Gert, et al.
Publicado: (2022)

Activity of Oritavancin against Gram-Positive Pathogens Causing Bloodstream Infections in the United States over 10 Years: Focus on Drug-Resistant Enterococcal Subsets (2010–2019)
por: Carvalhaes, Cecilia G., et al.
Publicado: (2022)

In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions
por: Pfaller, Michael A., et al.
Publicado: (2017)

Disease Surveillance Among U.S.-Bound Immigrants and Refugees — Electronic Disease Notification System, United States, 2014–2019
por: Phares, Christina R., et al.
Publicado: (2022)

Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)
por: Pfaller, M. A., et al.
Publicado: (2022)

Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019
por: Estabrook, Mark, et al.
Publicado: (2023)

Genomic Screening of Antimicrobial Resistance Markers in UK and US Campylobacter Isolates Highlights Stability of Resistance over an 18-Year Period
por: van Vliet, Arnoud H. M., et al.
Publicado: (2022)

2529. Population pharmacokinetic models for cefepime and enmetazobactam derived from pooled Phase 1 to Phase 3 clinical studies
por: Vollmer, Jannik, et al.
Publicado: (2023)

Genomic Analysis of a Strain Collection Containing Multidrug-, Extensively Drug-, Pandrug-, and Carbapenem-Resistant Modern Clinical Isolates of Acinetobacter baumannii
por: Valcek, Adam, et al.
Publicado: (2022)

Distribution of Chronic Obstructive Pulmonary Disease — China, 2014−2015
por: Wang, Ning, et al.
Publicado: (2020)

Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893
por: Tabor, David E., et al.
Publicado: (2016)

Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against Pathogens Harboring OXA-48 and AmpC Alone or in Combination with Other β-Lactamases Collected from Phase 3 Clinical Trials and an International Surveillance Program
por: Lin, Lynn-Yao, et al.
Publicado: (2022)

Epidemiologic Trends of Dengue in U.S. Territories, 2010–2020
por: Ryff, Kyle R., et al.
Publicado: (2023)

Travel-Related Diagnoses Among U.S. Nonmigrant Travelers or Migrants Presenting to U.S. GeoSentinel Sites — GeoSentinel Network, 2012–2021
por: Brown, Ashley B., et al.
Publicado: (2023)

LB-4. Cefepime-Enmetazobactam Demonstrates Superiority to Piperacillin-Tazobactam in a Subgroup of Patients with Complicated Urinary Tract Infections/Acute Pyelonephritis Caused by Extended Spectrum β-Lactamase-Producing Enterobacterales
por: Belley, Adam, et al.
Publicado: (2020)

Healthcare-associated infections by multidrug-resistant bacteria in Andalusia, Spain, 2014 to 2021
por: Fernández-Martínez, Nicolás Francisco, et al.
Publicado: (2023)

Epidemiology of human West Nile virus infections in the European Union and European Union enlargement countries, 2010 to 2018
por: Young, Johanna J, et al.
Publicado: (2021)

1477. A Randomized Phase 2 Study of Cefepime Combined with the Novel Extended Spectrum β-Lactamase Inhibitor Enmetazobactam in Hospitalized Adults with Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP)
por: Carmeli, Yehuda, et al.
Publicado: (2019)

From the threat to the large outbreak: dengue on Reunion Island, 2015 to 2018
por: Vincent, Muriel, et al.
Publicado: (2019)

Diphtheria in the WHO European Region, 2010 to 2019
por: Muscat, Mark, et al.
Publicado: (2022)

Provincial trends in Legionnaires’ disease are not explained by population structure in Denmark, 2015 to 2018
por: Cassell, Kelsie, et al.
Publicado: (2021)

Group A rotavirus surveillance before vaccine introduction in Italy, September 2014 to August 2017
por: Ianiro, Giovanni, et al.
Publicado: (2019)

Trends in tuberculosis notification and mortality and factors associated with treatment outcomes in Serbia, 2005 to 2015
por: Stosic, Maja, et al.
Publicado: (2020)

Arthropod-borne diseases among travellers arriving in Europe from Africa, 2015 to 2019
por: Gossner, Céline M, et al.
Publicado: (2023)

Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017
por: Iacchini, Simone, et al.
Publicado: (2019)

Tuberculosis treatment outcomes of notified cases: trends and determinants of potential unfavourable outcome, France, 2008 to 2014
por: Guthmann, Jean-Paul, et al.
Publicado: (2020)

Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus
por: Enkirch, Theresa, et al.
Publicado: (2019)

Piloting a surveillance system for HIV drug resistance in the European Union
por: van de Laar, Marita JW, et al.
Publicado: (2019)

A step forward in antibiotic use and resistance monitoring: a quarterly surveillance system pilot in 11 European Union/European Economic Area countries, September 2017 to May 2020
por: Peñalva, Germán, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tumfg9boif1av4jo1rqo9u4fc4